A Phase 1, Multicenter, Open-Label, Dose Escalation, Dose Expansion and Dose Confirmation Study of BHV-1530 in Adult Participants with Advanced or Metastatic Solid Tumors

Enrollment
This study is currently enrolling.
Associated Conditions
- Multitherapeutic
Research Area
Clinical Cancer Research
Location

Celebration
Principal Investigator

Guru Sonpavde, MD
Sponsor

Biohaven Therapeutics Inc

Enrollment Form

This study is currently enrolling.